Target-Based Discovery of an Inhibitor of the Regulatory Phosphatase PPP1R15B

Summary Protein phosphorylation is a prevalent and ubiquitous mechanism of regulation. Kinases are popular drug targets, but identifying selective phosphatase inhibitors has been challenging. Here, we used surface plasmon resonance to design a method to enable target-based discovery of selective serine/threonine phosphatase inhibitors. The method targeted a regulatory subunit of protein phosphatase 1, PPP1R15B (R15B), a negative regulator of proteostasis. This yielded Raphin1, a selective inhibitor of R15B. In cells, Raphin1 caused a rapid and transient accumulation of its phosphorylated substrate, resulting in a transient attenuation of protein synthesis. In vitro, Raphin1 inhibits the recombinant R15B-PP1c holoenzyme, but not the closely related R15A-PP1c, by interfering with substrate recruitment. Raphin1 was orally bioavailable, crossed the blood-brain barrier, and demonstrated efficacy in a mouse model of Huntington’s disease. This identifies R15B as a druggable target and provides a platform for target-based discovery of inhibitors of serine/threonine phosphatases.

[1]  D. Scheuner,et al.  Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2α) dephosphorylation in mammalian development , 2009, Proceedings of the National Academy of Sciences.

[2]  R. Deshaies,et al.  Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy , 2014, BMC Biology.

[3]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[4]  M. Bollen,et al.  The PP1 binding code: a molecular‐lego strategy that governs specificity , 2013, The FEBS journal.

[5]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[6]  S. Shenolikar,et al.  From promiscuity to precision: protein phosphatases get a makeover. , 2009, Molecular cell.

[7]  K. Nader,et al.  eIF2α Phosphorylation Bidirectionally Regulates the Switch from Short- to Long-Term Synaptic Plasticity and Memory , 2007, Cell.

[8]  Ben C. Collins,et al.  AP-SWATH Reveals Direct Involvement of VCP/p97 in Integrated Stress Response Signaling Through Facilitating CReP/PPP1R15B Degradation * , 2018, Molecular & Cellular Proteomics.

[9]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[10]  Hugo Kubinyi,et al.  Similarity and Dissimilarity: A Medicinal Chemist’s View , 2002 .

[11]  M. Bollen,et al.  Interactor-guided dephosphorylation by protein phosphatase-1. , 2013, Methods in molecular biology.

[12]  D. Ron,et al.  Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. , 2001, Molecular cell.

[13]  A. Singleton,et al.  The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases , 2016, Neuron.

[14]  Jennifer L Mamrosh,et al.  p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates , 2017, Proceedings of the National Academy of Sciences.

[15]  Kim Schneider,et al.  Coping with Protein Quality Control Failure. , 2017, Annual review of cell and developmental biology.

[16]  E McEwen,et al.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis. , 2001, Molecular cell.

[17]  D. Ron,et al.  Stress‐induced gene expression requires programmed recovery from translational repression , 2003, The EMBO journal.

[18]  Richard I. Morimoto,et al.  Adapting Proteostasis for Disease Intervention , 2008, Science.

[19]  S. Villa-Treviño,et al.  Induction of fatty liver in the rat after cycloheximide administration. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[20]  D. Waugh,et al.  Site-specific, enzymatic biotinylation of recombinant proteins in Spodoptera frugiperda cells using biotin acceptor peptides. , 1998, Analytical biochemistry.

[21]  D. Kirschner,et al.  Different Intracellular Pathomechanisms Produce Diverse Myelin Protein Zero Neuropathies in Transgenic Mice , 2006, The Journal of Neuroscience.

[22]  C. Hetz,et al.  Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. , 2012, Human molecular genetics.

[23]  G. Wagner,et al.  Solution structure of human initiation factor eIF2alpha reveals homology to the elongation factor eEF1B. , 2004, Structure.

[24]  P. Cohen,et al.  On target with a new mechanism for the regulation of protein phosphorylation. , 1993, Trends in biochemical sciences.

[25]  D. Fabbro,et al.  Advances in kinase targeting: current clinical use and clinical trials. , 2014, Trends in pharmacological sciences.

[26]  D. Ron,et al.  13 eIF2α Phosphorylation in Cellular Stress Responses and Disease , 2007 .

[27]  D. Ron,et al.  Inhibition of a constitutive translation initiation factor 2α phosphatase, CReP, promotes survival of stressed cells , 2003, The Journal of cell biology.

[28]  E. Snapp,et al.  Changes in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin , 2011, Journal of Cell Science.

[29]  A. Bertolotti.  Importance of the subcellular location of protein deposits in neurodegenerative diseases , 2018, Current Opinion in Neurobiology.

[30]  D. Ron,et al.  Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α , 2001, The Journal of cell biology.

[31]  M. Schapira,et al.  Regulated translation initiation controls stress-induced gene expression in mammalian cells. , 2000, Molecular cell.

[32]  D. Brautigan,et al.  Protein Ser/ Thr phosphatases – the ugly ducklings of cell signalling , 2013, The FEBS journal.

[33]  H Roos,et al.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. , 2000, Journal of medicinal chemistry.

[34]  Susan Lindquist,et al.  A network of protein interactions determines polyglutamine toxicity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Hendershot,et al.  Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. , 2002, Journal of molecular biology.

[36]  A. Bertolotti,et al.  Exploiting the selectivity of protein phosphatase 1 for pharmacological intervention , 2013, The FEBS journal.

[37]  Camille G Wermuth,et al.  Selective optimization of side activities: the SOSA approach. , 2006, Drug discovery today.

[38]  M. Cyert,et al.  Cracking the Phosphatase Code: Docking Interactions Determine Substrate Specificity , 2009, Science Signaling.

[39]  A. Bertolotti,et al.  Decoding the selectivity of eIF2α holophosphatases and PPP1R15A inhibitors , 2017, Nature Structural &Molecular Biology.

[40]  A. McCluskey,et al.  Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. , 2002, Journal of medicinal chemistry.

[41]  Kim Schneider,et al.  Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit , 2015, Science.

[42]  D. Myszka,et al.  Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.

[43]  B. Barak,et al.  ER Stress-Induced eIF2-alpha Phosphorylation Underlies Sensitivity of Striatal Neurons to Pathogenic Huntingtin , 2014, PloS one.

[44]  G. Lederkremer,et al.  Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress , 2013, Nature Communications.

[45]  T. Anthony,et al.  Transcription factor ATF4 directs basal and stress-induced gene expression in the unfolded protein response and cholesterol metabolism in the liver , 2016, Molecular biology of the cell.

[46]  Naoki Omori,et al.  Subtleties in GPCR drug discovery: a medicinal chemistry perspective. , 2012, Drug discovery today.

[47]  D. Ron,et al.  Selective Inhibition of a Regulatory Subunit of Protein Phosphatase 1 Restores Proteostasis , 2011, Science.

[48]  Patricia T W Cohen,et al.  Protein phosphatase 1--targeted in many directions. , 2002, Journal of cell science.

[49]  M. Bollen,et al.  The extended PP1 toolkit: designed to create specificity. , 2010, Trends in biochemical sciences.

[50]  R. Morimoto,et al.  Biological and chemical approaches to diseases of proteostasis deficiency. , 2009, Annual review of biochemistry.

[51]  E. Jan,et al.  An Upstream Open Reading Frame Regulates Translation of GADD34 during Cellular Stresses That Induce eIF2α Phosphorylation* , 2009, Journal of Biological Chemistry.

[52]  Anthony M Giannetti,et al.  From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance. , 2011, Methods in enzymology.

[53]  L. Kuo,et al.  Fragment-based drug design : tools, practical approaches, and examples , 2011 .

[54]  Y. Martin,et al.  Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.

[55]  A. Hattersley,et al.  A Missense Mutation in PPP1R15B Causes a Syndrome Including Diabetes, Short Stature, and Microcephaly , 2015, Diabetes.

[56]  Maja Köhn,et al.  Challenges and opportunities in the development of protein phosphatase-directed therapeutics. , 2013, ACS chemical biology.

[57]  H. Meyer,et al.  VCP/p97-Mediated Unfolding as a Principle in Protein Homeostasis and Signaling. , 2017, Molecular cell.

[58]  D. Borchelt,et al.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. , 1999, Human molecular genetics.

[59]  R. Kaufman,et al.  Phosphorylation of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis in Response to Activation of the Double-stranded RNA-dependent Protein Kinase* , 1998, The Journal of Biological Chemistry.